Search Results: benefits/ (3)

An interesting finding

Here’s your daily round up of pot news, excerpted from the newsletter WeedWeek.

The Centers for Disease Control found that more Americans are using cannabis but the abuse rate has fallen. For additional details see here.

At the L.A. Times, Robin Abcarian looks at the links between cannabis use and psychosis.

A study found that being high decreases cannabis users’ motivation, but that it returned when they were sober.

The DEA said it would add the psychotropic tropical plant kratom, which some consider to have health benefits, to its list of schedule I substances, alongside LSD, heroin, cannabis and other drugs it considers to have no medical uses.

Israeli doctors will begin a first of its kind study to test the effects of cannabis on individuals with autism. The country also plans to start exporting MED.

New York state will expand its MED program, and allow home delivery. Crain’s New York Business asks if the state will allow the industry to thrive. Oregon licensed its first two testing labs.

This month, a Manhattan gallery owner known as Mr. Grey will host an exhibit of bongs valued between $500 and $250,000. You can see pieces from his collection on his Instagram page.

The Forward has a “ Pot Shabbat” with “Jeff the 420 Chef.” The challah, matzo balls, Brussels sprouts, potatoes and cookies were all laced.

Vice meets an Englishman who legally changed his name to “ Free Cannabis.” He planted cannabis in Glastonbury’s celebrated flower displays.

A new cannabis social network caters to seniors. Jimi Hendrix is enshrined in a new line of edibles.

The great comedian Gene Wilder died. Though it did not make the connection, The Cannabist reviewed Snozzberry, an indica dominant hybrid, named for a fruit invented by Willy Wonka. Wilder also appears to smoke weed in “Blazing Saddles.”

Graphic: Four Twenty Studios

​​​Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.


Worth Repeating
By Ron Marczyk, R.N.
Health Education Teacher (Retired)

An Israeli study finds that the cannabinoids in cannabis provide relief from anxiety due to stress. This study suggests that a treatment to heal a hyper-alert “fear memory” in post-traumatic stress disorder (PTSD) patients may exist.

Medical cannabis may also enhance PTSD behavior therapy treatments as an anti-anxiety agent that resets a damaged amygdala and may act as a superior psychiatric medicine to present-day antidepressants and anti-anxiety drugs.